Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma

OBJECTIVE: The aim of the study was to determine whether atherosclerotic risk markers exist at the moment and after withdrawal of cabergoline (CAB) therapy in patients who had taken a suitable dose of CAB therapy for a suitable period of time before cessation of CAB. METHODS: This study was designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Doğan, Berçem Ayçiçek, Arduç, Ayşe, Tuna, Mazhar Müslüm, Nasıroğlu, Narin Imga, Işık, Serhat, Berker, Dilek, Güler, Serdar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331378/
https://www.ncbi.nlm.nih.gov/pubmed/26680550
http://dx.doi.org/10.5152/AnatolJCardiol.2015.6416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331378/
https://www.ncbi.nlm.nih.gov/pubmed/26680550
http://dx.doi.org/10.5152/AnatolJCardiol.2015.6416

Ejemplares similares